Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice
Mohammad Nazmul Hasan(University of Oklahoma Health Sciences Center), Tiangang Li(University of Oklahoma Health Sciences Center)
Cited by 19
Related Papers
Electrospinning Nanofibers for Therapeutics Delivery
|Nanomaterials|2019|288
An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis
|Nature Communications|2020|95
Insulin Regulation of Cholesterol 7α-Hydroxylase Expression in Human Hepatocytes
|Journal of Biological Chemistry|2006|85
Glucose stimulates cholesterol 7α-hydroxylase gene transcription in human hepatocytes
|Journal of Lipid Research|2009|83
Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice
|Journal of Lipid Research|2013|80